Updated:
IQVIA
IQVIA offers clinical research services, commercial insights, and healthcare intelligence. The company provides services such as clinical trial optimization,...
IQVIA
IQVIA offers clinical research services, commercial insights, and healthcare intelligence. The company provides services such as clinical trial optimization, real-world evidence generation, and commercialization of medical treatments, supported by analytics and AI technology. IQVIA serves sectors including biotechnology, medical devices, pharmaceuticals, and other healthcare stakeholders, and is based in Durham, North Carolina.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Danbury
Corporate office
Danbury, CT, United States
Sector focus
Frequently asked questions
Who runs investment decisions at IQVIA?
IQVIA is a publicly traded company (NYSE: IQV) with a board of directors led by CEO Ari Bousbib, who has served since 2016. Investment decisions for capital allocation — including R&D spending, acquisitions, and clinical trial investments — are made by the executive management team under board oversight (per SEC filings, 2025).
Is IQVIA structured as a family office or a commercial enterprise?
IQVIA is a publicly traded, for-profit corporation, not a family office. It generates revenue through contracts for clinical research, data licensing, and technology subscription services. Its NYSE listing and SEC filings confirm its status as a commercial entity, not a private capital vehicle (per IQVIA 10-K, 2024).
What investment stages does IQVIA target?
IQVIA does not function as an investment firm but as a service provider. However, it does make strategic acquisitions to enhance its technology and data capabilities, typically targeting early- to growth-stage healthcare IT and analytics companies. Recent acquisitions include 2022's purchase of Healthward (per IQVIA press release, 2022).
Which sectors does IQVIA explicitly focus on?
IQVIA operates exclusively within healthcare — covering pharmaceuticals, biotechnology, medical devices, and diagnostics. It does not service other industries such as finance, energy, or consumer goods (public record).
How does IQVIA source proprietary deal flow?
IQVIA's deal flow comes from its existing biopharma client relationships and the RFP processes for clinical trials. Proprietary data from its patient record database also informs new service offerings and technology development (per company overview, 2024).
Does IQVIA maintain philanthropic structures?
IQVIA does not disclose a separate philanthropic foundation in public filings. However, it operates corporate social responsibility initiatives, including the IQVIA Foundation, which directs grants to global health programs (per IQVIA CSR report, 2024).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: